151 related articles for article (PubMed ID: 10590375)
1. Incidence rate of satellite tumors in renal cell carcinoma.
Kinouchi T; Mano M; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
Cancer; 1999 Dec; 86(11):2331-6. PubMed ID: 10590375
[TBL] [Abstract][Full Text] [Related]
2. Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm. or less.
Gohji K; Hara I; Gotoh A; Eto H; Miyake H; Sugiyama T; Okada H; Arakawa S; Kamidono S
J Urol; 1998 Apr; 159(4):1144-7. PubMed ID: 9507818
[TBL] [Abstract][Full Text] [Related]
3. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
4. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
5. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma.
Sargin SY; Ekmekcioglu O; Arpali E; Altinel M; Voyvoda B
Urol Int; 2009; 82(3):324-9. PubMed ID: 19440022
[TBL] [Abstract][Full Text] [Related]
6. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy.
Whang M; O'Toole K; Bixon R; Brunetti J; Ikeguchi E; Olsson CA; Sawczuk TS; Benson MC
J Urol; 1995 Sep; 154(3):968-70; discussion 970-1. PubMed ID: 7637103
[TBL] [Abstract][Full Text] [Related]
7. Nephron-sparing surgery is still controversial for patients with renal cell carcinoma and normal contralateral kidney: risks predictable by AgNOR counts in satellite lesions.
Kobayashi M; Hashimoto S; Tokue A
Mol Urol; 2000; 4(1):21-9. PubMed ID: 10851303
[TBL] [Abstract][Full Text] [Related]
8. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
9. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
[TBL] [Abstract][Full Text] [Related]
10. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
11. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
13. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
[TBL] [Abstract][Full Text] [Related]
14. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
[TBL] [Abstract][Full Text] [Related]
15. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
16. [Satellite intrarenal tumor nodules in renal carcinoma. Therapeutic implications].
Gutiérrez Baños JL; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; Dél Valle Schaan JI; Roca Edreira A; Vega Vega A; Villanueva Peña A
Arch Esp Urol; 1996; 49(6):580-6. PubMed ID: 8929100
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma invading the urinary collecting system: implications for staging.
Uzzo RG; Cherullo E; Myles J; Novick AC
J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
[TBL] [Abstract][Full Text] [Related]
19. Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications.
Leibovitch I; Lev R; Mor Y; Golomb J; Dotan ZA; Ramon J
Isr Med Assoc J; 2001 Aug; 3(8):563-5. PubMed ID: 11519377
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma.
Minervini A; di Cristofano C; Lapini A; Marchi M; Lanzi F; Giubilei G; Tosi N; Tuccio A; Mancini M; della Rocca C; Serni S; Bevilacqua G; Carini M
Eur Urol; 2009 Jun; 55(6):1410-8. PubMed ID: 18692300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
